ID   NCOA2_HUMAN             Reviewed;        1464 AA.
AC   Q15596; Q14CD2;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 2.
DT   10-MAY-2017, entry version 192.
DE   RecName: Full=Nuclear receptor coactivator 2;
DE            Short=NCoA-2;
DE   AltName: Full=Class E basic helix-loop-helix protein 75;
DE            Short=bHLHe75;
DE   AltName: Full=Transcriptional intermediary factor 2;
DE            Short=hTIF2;
GN   Name=NCOA2; Synonyms=BHLHE75, SRC2, TIF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8670870;
RA   Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H.;
RT   "TIF2, a 160 kDa transcriptional mediator for the ligand-dependent
RT   activation function AF-2 of nuclear receptors.";
RL   EMBO J. 15:3667-3675(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-1282.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 870-939, AND CHROMOSOMAL TRANSLOCATION
RP   WITH KAT6A.
RX   PubMed=9558366;
RA   Carapeti M., Aguiar R.C.T., Goldman J.M., Cross N.C.P.;
RT   "A novel fusion between MOZ and the nuclear receptor coactivator TIF2
RT   in acute myeloid leukemia.";
RL   Blood 91:3127-3133(1998).
RN   [4]
RP   FUNCTION, INTERACTION WITH CREBBP; ESR1; RARA AND RXRA, DOMAIN, AND
RP   MUTAGENESIS OF 644-LEU-LEU-645; 693-LEU-LEU-694; 748-LEU-LEU-749;
RP   1079-LEU--LEU-1083 AND 1081-ASP-GLN-1082.
RX   PubMed=9430642; DOI=10.1093/emboj/17.2.507;
RA   Voegel J.J., Heine M.J.S., Tini M., Vivat V., Chambon P.,
RA   Gronemeyer H.;
RT   "The coactivator TIF2 contains three nuclear receptor-binding motifs
RT   and mediates transactivation through CBP binding-dependent and
RT   -independent pathways.";
RL   EMBO J. 17:507-519(1998).
RN   [5]
RP   INTERACTION WITH NR3C1.
RX   PubMed=9590696; DOI=10.1038/30032;
RA   Fryer C.J., Archer T.K.;
RT   "Chromatin remodelling by the glucocorticoid receptor requires the
RT   BRG1 complex.";
RL   Nature 393:88-91(1998).
RN   [6]
RP   INTERACTION WITH RORA.
RX   PubMed=10478845; DOI=10.1210/mend.13.9.0343;
RA   Atkins G.B., Hu X., Guenther M.G., Rachez C., Freedman L.P.,
RA   Lazar M.A.;
RT   "Coactivators for the orphan nuclear receptor RORalpha.";
RL   Mol. Endocrinol. 13:1550-1557(1999).
RN   [7]
RP   INTERACTION WITH HIF1A; NCOA1 AND APEX.
RX   PubMed=10594042; DOI=10.1128/MCB.20.1.402-415.2000;
RA   Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H.,
RA   Poellinger L.;
RT   "Redox-regulated recruitment of the transcriptional coactivators CREB-
RT   binding protein and SRC-1 to hypoxia-inducible factor 1alpha.";
RL   Mol. Cell. Biol. 20:402-415(2000).
RN   [8]
RP   INTERACTION WITH DDX5.
RX   PubMed=11250900; DOI=10.1093/emboj/20.6.1341;
RA   Watanabe M., Yanagisawa J., Kitagawa H., Takeyama K., Ogawa S.,
RA   Arao Y., Suzawa M., Kobayashi Y., Yano T., Yoshikawa H., Masuhiro Y.,
RA   Kato S.;
RT   "A subfamily of RNA-binding DEAD-box proteins acts as an estrogen
RT   receptor alpha coactivator through the N-terminal activation domain
RT   (AF-1) with an RNA coactivator, SRA.";
RL   EMBO J. 20:1341-1352(2001).
RN   [9]
RP   IDENTIFICATION IN A COACTIVATOR COMPLEX CONTAINING CREBBP; NCOA3;
RP   IKKA; IKKB AND IKBKG.
RX   PubMed=11971985; DOI=10.1128/MCB.22.10.3549-3561.2002;
RA   Wu R.-C., Qin J., Hashimoto Y., Wong J., Xu J., Tsai S.Y., Tsai M.-J.,
RA   O'Malley B.W.;
RT   "Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator
RT   activity by I kappa B kinase.";
RL   Mol. Cell. Biol. 22:3549-3561(2002).
RN   [10]
RP   CHROMOSOMAL TRANSLOCATION WITH KAT6A.
RX   PubMed=12676584; DOI=10.1016/S1535-6108(03)00051-5;
RA   Deguchi K., Ayton P.M., Carapeti M., Kutok J.L., Snyder C.S.,
RA   Williams I.R., Cross N.C.P., Glass C.K., Cleary M.L., Gilliland D.G.;
RT   "MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome
RT   binding motif and TIF2-mediated recruitment of CBP.";
RL   Cancer Cell 3:259-271(2003).
RN   [11]
RP   CHROMOSOMAL TRANSLOCATION WITH KAT6A.
RX   PubMed=15657427; DOI=10.1128/MCB.25.3.988-1002.2005;
RA   Kindle K.B., Troke P.J.F., Collins H.M., Matsuda S., Bossi D.,
RA   Bellodi C., Kalkhoven E., Salomoni P., Pelicci P.G., Minucci S.,
RA   Heery D.M.;
RT   "MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by
RT   impairment of CBP function.";
RL   Mol. Cell. Biol. 25:988-1002(2005).
RN   [12]
RP   INTERACTION WITH PSMB9.
RX   PubMed=16957778; DOI=10.1038/sj.emboj.7601306;
RA   Zhang H., Sun L., Liang J., Yu W., Zhang Y., Wang Y., Chen Y., Li R.,
RA   Sun X., Shang Y.;
RT   "The catalytic subunit of the proteasome is engaged in the entire
RT   process of estrogen receptor-regulated transcription.";
RL   EMBO J. 25:4223-4233(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   INTERACTION WITH TTLL5.
RC   TISSUE=Testis;
RX   PubMed=17116691; DOI=10.1128/MCB.01360-06;
RA   He Y., Simons S.S. Jr.;
RT   "STAMP, a novel predicted factor assisting TIF2 actions in
RT   glucocorticoid receptor-mediated induction and repression.";
RL   Mol. Cell. Biol. 27:1467-1485(2007).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-640; LYS-780 AND LYS-785,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487; SER-493 AND
RP   SER-499, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-493; SER-565;
RP   SER-682; SER-699; SER-736 AND SER-771, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH RWDD3 AND NR3C1.
RX   PubMed=23508108; DOI=10.1128/MCB.01470-12;
RA   Druker J., Liberman A.C., Antunica-Noguerol M., Gerez J.,
RA   Paez-Pereda M., Rein T., Iniguez-Lluhi J.A., Holsboer F., Arzt E.;
RT   "RSUME enhances glucocorticoid receptor SUMOylation and
RT   transcriptional activity.";
RL   Mol. Cell. Biol. 33:2116-2127(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493; SER-554; SER-565
RP   AND SER-699, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1173; ARG-1177; ARG-1190;
RP   ARG-1196; ARG-1203; ARG-1221; ARG-1261 AND ARG-1266, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-785, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
CC   -!- FUNCTION: Transcriptional coactivator for steroid receptors and
CC       nuclear receptors. Coactivator of the steroid binding domain (AF-
CC       2) but not of the modulating N-terminal domain (AF-1). Required
CC       with NCOA1 to control energy balance between white and brown
CC       adipose tissues. Critical regulator of glucose metabolism
CC       regulation, acts as RORA coactivator to specifically modulate G6PC
CC       expression. Involved in the positive regulation of the
CC       transcriptional activity of the glucocorticoid receptor NR3C1 by
CC       sumoylation enhancer RWDD3. Positively regulates the circadian
CC       clock by acting as a transcriptional coactivator for the CLOCK-
CC       ARNTL/BMAL1 heterodimer (By similarity).
CC       {ECO:0000250|UniProtKB:Q61026, ECO:0000269|PubMed:23508108,
CC       ECO:0000269|PubMed:9430642}.
CC   -!- SUBUNIT: Present in a complex containing NCOA3, IKKA, IKKB, IKBKG
CC       and CREBBP. Interacts (via C-terminus) with CREBBP. Interacts with
CC       ESR1, HIF1A, NCOA1, APEX, NR3C1, NR3C2, CARM1, RARA, and RXRA.
CC       Present in a complex containing CARM1 and EP300/P300. Interacts
CC       with CASP8AP2 and TTLL5/STAMP. Interacts with PSMB9 and DDX5.
CC       Interacts (via LXXLL 1, 2 and 3 motifs) with RORA and RORC (via
CC       AF-2 motif). Interacts with RWDD3. Interacts with CLOCK and
CC       ARNTL/BMAL1 (By similarity). Interacts with NR4A3; potentiates the
CC       activity of the NR4A3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q61026, ECO:0000269|PubMed:10478845,
CC       ECO:0000269|PubMed:10594042, ECO:0000269|PubMed:11250900,
CC       ECO:0000269|PubMed:11971985, ECO:0000269|PubMed:16957778,
CC       ECO:0000269|PubMed:17116691, ECO:0000269|PubMed:23508108,
CC       ECO:0000269|PubMed:9430642, ECO:0000269|PubMed:9590696}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=2; IntAct=EBI-81236, EBI-608057;
CC       Q92841:DDX17; NbExp=2; IntAct=EBI-81236, EBI-746012;
CC       P03372:ESR1; NbExp=8; IntAct=EBI-81236, EBI-78473;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DOMAIN: Contains four Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. The
CC       LXXLL motifs are essential for the association with nuclear
CC       receptors and are, at least in part, functionally redundant.
CC       {ECO:0000269|PubMed:9430642}.
CC   -!- DOMAIN: The LLXXLXXXL motif is involved in transcriptional
CC       coactivation and CREBBP/CBP binding. {ECO:0000269|PubMed:9430642}.
CC   -!- DOMAIN: Contains 2 C-terminal transcription activation domains
CC       (AD1 and AD2) that can function independently.
CC       {ECO:0000269|PubMed:9430642}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving NCOA2 may be a
CC       cause of acute myeloid leukemias. Inversion inv(8)(p11;q13)
CC       generates the KAT6A-NCOA2 oncogene, which consists of the N-
CC       terminal part of KAT6A and the C-terminal part of NCOA2/TIF2.
CC       KAT6A-NCOA2 binds to CREBBP and disrupts its function in
CC       transcription activation. {ECO:0000269|PubMed:12676584,
CC       ECO:0000269|PubMed:15657427, ECO:0000269|PubMed:9558366}.
CC   -!- SIMILARITY: Belongs to the SRC/p160 nuclear receptor coactivator
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97674; CAA66263.1; -; mRNA.
DR   EMBL; BC114383; AAI14384.1; -; mRNA.
DR   CCDS; CCDS47872.1; -.
DR   RefSeq; NP_001308632.1; NM_001321703.1.
DR   RefSeq; NP_001308636.1; NM_001321707.1.
DR   RefSeq; NP_001308640.1; NM_001321711.1.
DR   RefSeq; NP_001308641.1; NM_001321712.1.
DR   RefSeq; NP_001308642.1; NM_001321713.1.
DR   RefSeq; NP_006531.1; NM_006540.3.
DR   UniGene; Hs.446678; -.
DR   UniGene; Hs.595378; -.
DR   PDB; 1GWQ; X-ray; 2.45 A; C/D=688-696.
DR   PDB; 1GWR; X-ray; 2.40 A; C/D=742-750.
DR   PDB; 1M2Z; X-ray; 2.50 A; B/E=734-754.
DR   PDB; 1MV9; X-ray; 1.90 A; B=686-698.
DR   PDB; 1MVC; X-ray; 1.90 A; B=686-698.
DR   PDB; 1MZN; X-ray; 1.90 A; B/D/F/H=686-698.
DR   PDB; 1P93; X-ray; 2.70 A; E/F/G/H=740-751.
DR   PDB; 1T63; X-ray; 2.07 A; B=740-753.
DR   PDB; 1T65; X-ray; 1.66 A; B=686-698.
DR   PDB; 1UHL; X-ray; 2.90 A; C/D=687-696.
DR   PDB; 1YOK; X-ray; 2.50 A; B/C=740-753.
DR   PDB; 1ZDT; X-ray; 2.10 A; P/Q=741-752.
DR   PDB; 1ZDU; X-ray; 2.50 A; P/Q=741-751.
DR   PDB; 1ZKY; X-ray; 2.25 A; C/D=686-698.
DR   PDB; 2AO6; X-ray; 1.89 A; B=740-753.
DR   PDB; 2B1V; X-ray; 1.80 A; C/D=686-698.
DR   PDB; 2B1Z; X-ray; 1.78 A; C/D=686-698.
DR   PDB; 2B23; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 2FAI; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 2G44; X-ray; 2.65 A; C/D=686-698.
DR   PDB; 2G5O; X-ray; 2.30 A; C/D=686-698.
DR   PDB; 2LDC; NMR; -; A=687-697.
DR   PDB; 2P15; X-ray; 1.94 A; C/D=686-698.
DR   PDB; 2P1T; X-ray; 1.80 A; B=686-698.
DR   PDB; 2P1U; X-ray; 2.20 A; B=686-698.
DR   PDB; 2P1V; X-ray; 2.20 A; B=686-698.
DR   PDB; 2Q7J; X-ray; 1.90 A; B=740-753.
DR   PDB; 2Q7L; X-ray; 1.92 A; B=740-753.
DR   PDB; 2YJD; X-ray; 1.93 A; C/D=687-697.
DR   PDB; 2ZXZ; X-ray; 3.00 A; B=686-698.
DR   PDB; 2ZY0; X-ray; 2.90 A; B/D=686-698.
DR   PDB; 3A9E; X-ray; 2.75 A; I=686-698.
DR   PDB; 3CLD; X-ray; 2.84 A; C/H=740-751.
DR   PDB; 3DZU; X-ray; 3.20 A; E/G=685-697.
DR   PDB; 3DZY; X-ray; 3.10 A; E/G=685-697.
DR   PDB; 3E00; X-ray; 3.10 A; E/G=685-697.
DR   PDB; 3E7C; X-ray; 2.15 A; D/H=741-751.
DR   PDB; 3E94; X-ray; 1.90 A; B=686-698.
DR   PDB; 3ERD; X-ray; 2.03 A; C/D=686-698.
DR   PDB; 3FUG; X-ray; 2.00 A; B=686-698.
DR   PDB; 3GN8; X-ray; 2.50 A; C/E=734-754.
DR   PDB; 3K22; X-ray; 2.10 A; D/H=740-751.
DR   PDB; 3K23; X-ray; 3.00 A; D/E/F=740-751.
DR   PDB; 3KWY; X-ray; 2.30 A; B=686-698.
DR   PDB; 3KYT; X-ray; 2.35 A; C=686-697.
DR   PDB; 3L0E; X-ray; 2.30 A; B=740-751.
DR   PDB; 3L0J; X-ray; 2.40 A; C=688-697.
DR   PDB; 3L0L; X-ray; 1.74 A; C/E=685-697.
DR   PDB; 3O1D; X-ray; 2.40 A; B=686-698.
DR   PDB; 3O1E; X-ray; 2.50 A; B=686-698.
DR   PDB; 3OAP; X-ray; 2.05 A; B=686-696.
DR   PDB; 3OZJ; X-ray; 2.10 A; B/D=686-696.
DR   PDB; 3PCU; X-ray; 2.00 A; B=687-696.
DR   PDB; 3PLZ; X-ray; 1.75 A; C/D=740-753.
DR   PDB; 3Q95; X-ray; 2.05 A; C/D=686-698.
DR   PDB; 3Q97; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 3R5M; X-ray; 2.80 A; B/D=687-696.
DR   PDB; 3UP0; X-ray; 1.60 A; P/Q=740-753.
DR   PDB; 3UP3; X-ray; 1.25 A; P=741-754.
DR   PDB; 4CSJ; X-ray; 2.30 A; B=741-753.
DR   PDB; 4DOS; X-ray; 2.00 A; B/C=740-753.
DR   PDB; 4E2J; X-ray; 2.50 A; C/E=741-752.
DR   PDB; 4FHH; X-ray; 2.33 A; B=686-698.
DR   PDB; 4FHI; X-ray; 2.40 A; B=686-698.
DR   PDB; 4IA1; X-ray; 2.44 A; B=686-698.
DR   PDB; 4IA2; X-ray; 2.95 A; B=686-698.
DR   PDB; 4IA3; X-ray; 2.70 A; B=686-698.
DR   PDB; 4IA7; X-ray; 2.70 A; B=686-698.
DR   PDB; 4IQR; X-ray; 2.90 A; I/J/K/L=685-697.
DR   PDB; 4IU7; X-ray; 2.29 A; C/D=687-696.
DR   PDB; 4IUI; X-ray; 2.30 A; C/D=687-696.
DR   PDB; 4IV2; X-ray; 2.14 A; C/D=687-696.
DR   PDB; 4IV4; X-ray; 2.30 A; C/D=687-696.
DR   PDB; 4IVW; X-ray; 2.06 A; C/D=687-696.
DR   PDB; 4IVY; X-ray; 1.95 A; C/D=687-696.
DR   PDB; 4IW6; X-ray; 1.98 A; C/D=687-696.
DR   PDB; 4IW8; X-ray; 2.04 A; C/D=687-696.
DR   PDB; 4IWC; X-ray; 2.24 A; C/D=687-696.
DR   PDB; 4IWF; X-ray; 1.93 A; C/D=687-696.
DR   PDB; 4K4J; X-ray; 2.00 A; B=686-698.
DR   PDB; 4K6I; X-ray; 2.10 A; B=686-698.
DR   PDB; 4M8E; X-ray; 2.40 A; B=686-696.
DR   PDB; 4M8H; X-ray; 2.20 A; B=686-696.
DR   PDB; 4NIE; X-ray; 2.01 A; C/D=686-697.
DR   PDB; 4NQA; X-ray; 3.10 A; C/D/J/K=686-698.
DR   PDB; 4OC7; X-ray; 2.50 A; B=686-698.
DR   PDB; 4P6W; X-ray; 1.95 A; B=741-752.
DR   PDB; 4P6X; X-ray; 2.50 A; B/D/F/H/J/L=740-753.
DR   PDB; 4PLD; X-ray; 1.75 A; B=740-753.
DR   PDB; 4PLE; X-ray; 1.75 A; B/D/F/H=740-753.
DR   PDB; 4POH; X-ray; 2.30 A; B=686-698.
DR   PDB; 4POJ; X-ray; 2.00 A; B=686-698.
DR   PDB; 4PP3; X-ray; 2.00 A; B=686-698.
DR   PDB; 4PP5; X-ray; 2.00 A; B=686-698.
DR   PDB; 4PP6; X-ray; 2.20 A; C/D=688-696.
DR   PDB; 4PPP; X-ray; 2.69 A; C/D=688-696.
DR   PDB; 4PPS; X-ray; 1.93 A; C/D=687-698.
DR   PDB; 4PXM; X-ray; 1.90 A; C/D=686-698.
DR   PDB; 4Q0A; X-ray; 1.90 A; D=687-695.
DR   PDB; 4QE6; X-ray; 1.65 A; B=740-752.
DR   PDB; 4QE8; X-ray; 2.62 A; C/D=740-752.
DR   PDB; 4RFW; X-ray; 2.40 A; G=686-698.
DR   PDB; 4RMC; X-ray; 2.70 A; B=686-698.
DR   PDB; 4RMD; X-ray; 1.90 A; B=686-698.
DR   PDB; 4RME; X-ray; 2.30 A; B=686-698.
DR   PDB; 4RUO; X-ray; 2.81 A; B=686-698.
DR   PDB; 4UDC; X-ray; 2.50 A; B=740-753.
DR   PDB; 4UDD; X-ray; 1.80 A; B=740-753.
DR   PDB; 4WG0; X-ray; 1.82 A; A/B/C/D/E/F/G/H/I/J/K/L/M=742-752.
DR   PDB; 4ZN7; X-ray; 1.93 A; C/D=686-698.
DR   PDB; 4ZN9; X-ray; 2.21 A; C/D=686-698.
DR   PDB; 4ZNH; X-ray; 1.93 A; C/D=686-698.
DR   PDB; 4ZNS; X-ray; 1.86 A; C/D=686-698.
DR   PDB; 4ZNT; X-ray; 1.90 A; C/D=686-698.
DR   PDB; 4ZNU; X-ray; 2.40 A; C/D=686-698.
DR   PDB; 4ZNV; X-ray; 1.77 A; C/D=686-698.
DR   PDB; 4ZNW; X-ray; 2.31 A; C/D=686-698.
DR   PDB; 4ZO1; X-ray; 3.22 A; A=686-694.
DR   PDB; 4ZSH; X-ray; 1.80 A; B=686-698.
DR   PDB; 5APH; X-ray; 1.54 A; C=686-697.
DR   PDB; 5APJ; X-ray; 2.08 A; C=686-697.
DR   PDB; 5DI7; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DID; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DIE; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DIG; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DK9; X-ray; 2.28 A; C/D=686-699.
DR   PDB; 5DKB; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5DKE; X-ray; 2.60 A; C/D=686-699.
DR   PDB; 5DKG; X-ray; 2.15 A; C/D=686-699.
DR   PDB; 5DKS; X-ray; 2.60 A; C/D=686-699.
DR   PDB; 5DL4; X-ray; 2.10 A; C/D=686-699.
DR   PDB; 5DLR; X-ray; 2.26 A; C/D=686-699.
DR   PDB; 5DMC; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5DMF; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5DP0; X-ray; 2.38 A; C/D=686-699.
DR   PDB; 5DRJ; X-ray; 2.07 A; C/D=686-699.
DR   PDB; 5DRM; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DTV; X-ray; 2.29 A; C/D=686-699.
DR   PDB; 5DU5; X-ray; 2.19 A; C/D=686-699.
DR   PDB; 5DUE; X-ray; 2.09 A; C/D=686-699.
DR   PDB; 5DUG; X-ray; 2.25 A; C/D=686-699.
DR   PDB; 5DUH; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DVS; X-ray; 2.28 A; C/D=686-699.
DR   PDB; 5DVV; X-ray; 2.50 A; C/D=686-699.
DR   PDB; 5DWE; X-ray; 1.92 A; C/D=686-699.
DR   PDB; 5DWG; X-ray; 2.30 A; C/D=686-699.
DR   PDB; 5DWI; X-ray; 2.43 A; C/D=686-699.
DR   PDB; 5DWJ; X-ray; 2.00 A; C/D=686-699.
DR   PDB; 5DX3; X-ray; 2.09 A; C/D=687-697.
DR   PDB; 5DXB; X-ray; 2.08 A; D/E=687-697.
DR   PDB; 5DXE; X-ray; 1.50 A; C/D=687-697.
DR   PDB; 5DXK; X-ray; 2.23 A; C/D=686-699.
DR   PDB; 5DXM; X-ray; 2.37 A; C/D=686-699.
DR   PDB; 5DXP; X-ray; 2.20 A; C/D=686-699.
DR   PDB; 5DXQ; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5DXR; X-ray; 2.28 A; C/D=686-699.
DR   PDB; 5DY8; X-ray; 2.03 A; C/D=686-699.
DR   PDB; 5DYB; X-ray; 2.27 A; C/D=686-699.
DR   PDB; 5DYD; X-ray; 2.48 A; C/D=686-699.
DR   PDB; 5DZ0; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5DZ1; X-ray; 2.20 A; C/D=686-699.
DR   PDB; 5DZ3; X-ray; 2.15 A; C/D=686-699.
DR   PDB; 5DZH; X-ray; 2.11 A; C/D=686-699.
DR   PDB; 5DZI; X-ray; 1.90 A; C/D=686-699.
DR   PDB; 5E0W; X-ray; 2.00 A; C/D=686-699.
DR   PDB; 5E0X; X-ray; 2.01 A; C/D=686-699.
DR   PDB; 5E14; X-ray; 2.22 A; C/D=686-699.
DR   PDB; 5E15; X-ray; 2.10 A; C/D=686-699.
DR   PDB; 5E19; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5E1C; X-ray; 1.98 A; C/D=686-699.
DR   PDB; 5EC9; X-ray; 2.30 A; B=686-696.
DR   PDB; 5EGV; X-ray; 2.86 A; C/D=686-699.
DR   PDB; 5EHJ; X-ray; 2.50 A; C/D=686-699.
DR   PDB; 5EI1; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5EIT; X-ray; 2.68 A; C/D=686-699.
DR   PDB; 5G3J; X-ray; 2.40 A; B=740-753.
DR   PDB; 5G42; X-ray; 1.72 A; C=688-697.
DR   PDB; 5G43; X-ray; 2.58 A; C=686-697.
DR   PDB; 5G44; X-ray; 1.84 A; C=686-697.
DR   PDB; 5G45; X-ray; 2.07 A; C=688-697.
DR   PDB; 5G46; X-ray; 1.76 A; C=688-697.
DR   PDB; 5G5W; X-ray; 2.20 A; B=740-753.
DR   PDB; 5H1E; X-ray; 2.60 A; C=740-752.
DR   PDB; 5HYR; X-ray; 2.27 A; F/G=687-697.
DR   PDB; 5I4V; X-ray; 2.61 A; A/B/E/F=687-699.
DR   PDB; 5IAW; X-ray; 2.58 A; C/D=742-751.
DR   PDB; 5ICK; X-ray; 2.47 A; C/D=742-752.
DR   PDB; 5KCC; X-ray; 2.39 A; C/D=686-699.
DR   PDB; 5KCD; X-ray; 1.82 A; C/D=686-699.
DR   PDB; 5KCE; X-ray; 1.85 A; C/D=686-698, C/D=687-696.
DR   PDB; 5KCF; X-ray; 2.07 A; C/D=686-699.
DR   PDB; 5KCT; X-ray; 1.60 A; C/D=686-699.
DR   PDB; 5KCU; X-ray; 2.03 A; C/D=686-699.
DR   PDB; 5KCW; X-ray; 1.91 A; C/D=686-699.
DR   PDB; 5KD9; X-ray; 1.78 A; C/D=686-699.
DR   PDB; 5KR9; X-ray; 2.25 A; C/D=686-699.
DR   PDB; 5KRA; X-ray; 2.40 A; C/D/G/H=686-699.
DR   PDB; 5KRC; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5KRF; X-ray; 2.19 A; C/D=686-699.
DR   PDB; 5KRH; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5KRI; X-ray; 2.25 A; C/D=686-699.
DR   PDB; 5KRJ; X-ray; 2.70 A; C/D=686-699.
DR   PDB; 5KRK; X-ray; 2.39 A; C/D=686-699.
DR   PDB; 5KRL; X-ray; 2.40 A; C/D=686-699.
DR   PDB; 5KRM; X-ray; 2.24 A; C/D=686-699.
DR   PDB; 5KRO; X-ray; 2.10 A; C/D=686-699.
DR   PDB; 5L11; X-ray; 1.85 A; C=740-753.
DR   PDB; 5LGA; X-ray; 2.50 A; B=686-698.
DR   PDB; 5SYZ; X-ray; 1.93 A; C=740-754.
DR   PDB; 5TLD; X-ray; 2.38 A; C/D=686-698.
DR   PDB; 5TLF; X-ray; 2.20 A; C/D=686-698.
DR   PDB; 5TLG; X-ray; 2.23 A; C/D=686-698.
DR   PDB; 5TLL; X-ray; 2.42 A; C/D=686-698.
DR   PDB; 5TLM; X-ray; 2.50 A; C/D=686-698.
DR   PDB; 5TLO; X-ray; 2.28 A; C/D=686-698.
DR   PDB; 5TLP; X-ray; 2.08 A; C/D=686-698.
DR   PDB; 5TLT; X-ray; 1.90 A; C/D=686-698.
DR   PDB; 5TLU; X-ray; 2.22 A; C/D=686-698.
DR   PDB; 5TLV; X-ray; 2.32 A; C/D=686-698.
DR   PDB; 5TLX; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 5TLY; X-ray; 2.14 A; C/D=686-698.
DR   PDB; 5TM1; X-ray; 2.23 A; C/D=686-698.
DR   PDB; 5TM2; X-ray; 2.60 A; C/D=686-698.
DR   PDB; 5TM3; X-ray; 2.19 A; C/D=686-698.
DR   PDB; 5TM4; X-ray; 2.25 A; C/D=686-698.
DR   PDB; 5TM5; X-ray; 2.24 A; C/D=686-698.
DR   PDB; 5TM6; X-ray; 2.54 A; C/D=686-698.
DR   PDB; 5TM7; X-ray; 2.40 A; C/D=686-698.
DR   PDB; 5TM8; X-ray; 1.99 A; C/D=686-698.
DR   PDB; 5TM9; X-ray; 2.50 A; C/D=686-698.
DR   PDB; 5TML; X-ray; 2.25 A; C/D=686-698.
DR   PDB; 5TMM; X-ray; 2.20 A; C/D=686-698.
DR   PDB; 5TMO; X-ray; 2.17 A; C/D=686-698.
DR   PDB; 5TMQ; X-ray; 2.24 A; C/D=686-698.
DR   PDB; 5TMR; X-ray; 2.30 A; C/D=686-698.
DR   PDB; 5TMS; X-ray; 2.24 A; C/D=686-698.
DR   PDB; 5TMT; X-ray; 2.05 A; C/D=686-698.
DR   PDB; 5TMU; X-ray; 2.43 A; C/D=686-698.
DR   PDB; 5TMV; X-ray; 2.38 A; C/D=686-698.
DR   PDB; 5TMW; X-ray; 2.29 A; C/D=686-698.
DR   PDB; 5TMZ; X-ray; 2.21 A; C/D=686-698.
DR   PDB; 5TN1; X-ray; 2.06 A; C/D=686-698.
DR   PDB; 5TN3; X-ray; 2.54 A; C/D=686-698.
DR   PDB; 5TN4; X-ray; 1.86 A; C/D=686-698.
DR   PDB; 5TN5; X-ray; 1.89 A; C/D=686-698.
DR   PDB; 5TN6; X-ray; 2.09 A; C/D=686-698.
DR   PDB; 5TN7; X-ray; 2.24 A; C/D=686-698.
DR   PDB; 5TN8; X-ray; 2.65 A; C/D=686-698.
DR   PDBsum; 1GWQ; -.
DR   PDBsum; 1GWR; -.
DR   PDBsum; 1M2Z; -.
DR   PDBsum; 1MV9; -.
DR   PDBsum; 1MVC; -.
DR   PDBsum; 1MZN; -.
DR   PDBsum; 1P93; -.
DR   PDBsum; 1T63; -.
DR   PDBsum; 1T65; -.
DR   PDBsum; 1UHL; -.
DR   PDBsum; 1YOK; -.
DR   PDBsum; 1ZDT; -.
DR   PDBsum; 1ZDU; -.
DR   PDBsum; 1ZKY; -.
DR   PDBsum; 2AO6; -.
DR   PDBsum; 2B1V; -.
DR   PDBsum; 2B1Z; -.
DR   PDBsum; 2B23; -.
DR   PDBsum; 2FAI; -.
DR   PDBsum; 2G44; -.
DR   PDBsum; 2G5O; -.
DR   PDBsum; 2LDC; -.
DR   PDBsum; 2P15; -.
DR   PDBsum; 2P1T; -.
DR   PDBsum; 2P1U; -.
DR   PDBsum; 2P1V; -.
DR   PDBsum; 2Q7J; -.
DR   PDBsum; 2Q7L; -.
DR   PDBsum; 2YJD; -.
DR   PDBsum; 2ZXZ; -.
DR   PDBsum; 2ZY0; -.
DR   PDBsum; 3A9E; -.
DR   PDBsum; 3CLD; -.
DR   PDBsum; 3DZU; -.
DR   PDBsum; 3DZY; -.
DR   PDBsum; 3E00; -.
DR   PDBsum; 3E7C; -.
DR   PDBsum; 3E94; -.
DR   PDBsum; 3ERD; -.
DR   PDBsum; 3FUG; -.
DR   PDBsum; 3GN8; -.
DR   PDBsum; 3K22; -.
DR   PDBsum; 3K23; -.
DR   PDBsum; 3KWY; -.
DR   PDBsum; 3KYT; -.
DR   PDBsum; 3L0E; -.
DR   PDBsum; 3L0J; -.
DR   PDBsum; 3L0L; -.
DR   PDBsum; 3O1D; -.
DR   PDBsum; 3O1E; -.
DR   PDBsum; 3OAP; -.
DR   PDBsum; 3OZJ; -.
DR   PDBsum; 3PCU; -.
DR   PDBsum; 3PLZ; -.
DR   PDBsum; 3Q95; -.
DR   PDBsum; 3Q97; -.
DR   PDBsum; 3R5M; -.
DR   PDBsum; 3UP0; -.
DR   PDBsum; 3UP3; -.
DR   PDBsum; 4CSJ; -.
DR   PDBsum; 4DOS; -.
DR   PDBsum; 4E2J; -.
DR   PDBsum; 4FHH; -.
DR   PDBsum; 4FHI; -.
DR   PDBsum; 4IA1; -.
DR   PDBsum; 4IA2; -.
DR   PDBsum; 4IA3; -.
DR   PDBsum; 4IA7; -.
DR   PDBsum; 4IQR; -.
DR   PDBsum; 4IU7; -.
DR   PDBsum; 4IUI; -.
DR   PDBsum; 4IV2; -.
DR   PDBsum; 4IV4; -.
DR   PDBsum; 4IVW; -.
DR   PDBsum; 4IVY; -.
DR   PDBsum; 4IW6; -.
DR   PDBsum; 4IW8; -.
DR   PDBsum; 4IWC; -.
DR   PDBsum; 4IWF; -.
DR   PDBsum; 4K4J; -.
DR   PDBsum; 4K6I; -.
DR   PDBsum; 4M8E; -.
DR   PDBsum; 4M8H; -.
DR   PDBsum; 4NIE; -.
DR   PDBsum; 4NQA; -.
DR   PDBsum; 4OC7; -.
DR   PDBsum; 4P6W; -.
DR   PDBsum; 4P6X; -.
DR   PDBsum; 4PLD; -.
DR   PDBsum; 4PLE; -.
DR   PDBsum; 4POH; -.
DR   PDBsum; 4POJ; -.
DR   PDBsum; 4PP3; -.
DR   PDBsum; 4PP5; -.
DR   PDBsum; 4PP6; -.
DR   PDBsum; 4PPP; -.
DR   PDBsum; 4PPS; -.
DR   PDBsum; 4PXM; -.
DR   PDBsum; 4Q0A; -.
DR   PDBsum; 4QE6; -.
DR   PDBsum; 4QE8; -.
DR   PDBsum; 4RFW; -.
DR   PDBsum; 4RMC; -.
DR   PDBsum; 4RMD; -.
DR   PDBsum; 4RME; -.
DR   PDBsum; 4RUO; -.
DR   PDBsum; 4UDC; -.
DR   PDBsum; 4UDD; -.
DR   PDBsum; 4WG0; -.
DR   PDBsum; 4ZN7; -.
DR   PDBsum; 4ZN9; -.
DR   PDBsum; 4ZNH; -.
DR   PDBsum; 4ZNS; -.
DR   PDBsum; 4ZNT; -.
DR   PDBsum; 4ZNU; -.
DR   PDBsum; 4ZNV; -.
DR   PDBsum; 4ZNW; -.
DR   PDBsum; 4ZO1; -.
DR   PDBsum; 4ZSH; -.
DR   PDBsum; 5APH; -.
DR   PDBsum; 5APJ; -.
DR   PDBsum; 5DI7; -.
DR   PDBsum; 5DID; -.
DR   PDBsum; 5DIE; -.
DR   PDBsum; 5DIG; -.
DR   PDBsum; 5DK9; -.
DR   PDBsum; 5DKB; -.
DR   PDBsum; 5DKE; -.
DR   PDBsum; 5DKG; -.
DR   PDBsum; 5DKS; -.
DR   PDBsum; 5DL4; -.
DR   PDBsum; 5DLR; -.
DR   PDBsum; 5DMC; -.
DR   PDBsum; 5DMF; -.
DR   PDBsum; 5DP0; -.
DR   PDBsum; 5DRJ; -.
DR   PDBsum; 5DRM; -.
DR   PDBsum; 5DTV; -.
DR   PDBsum; 5DU5; -.
DR   PDBsum; 5DUE; -.
DR   PDBsum; 5DUG; -.
DR   PDBsum; 5DUH; -.
DR   PDBsum; 5DVS; -.
DR   PDBsum; 5DVV; -.
DR   PDBsum; 5DWE; -.
DR   PDBsum; 5DWG; -.
DR   PDBsum; 5DWI; -.
DR   PDBsum; 5DWJ; -.
DR   PDBsum; 5DX3; -.
DR   PDBsum; 5DXB; -.
DR   PDBsum; 5DXE; -.
DR   PDBsum; 5DXK; -.
DR   PDBsum; 5DXM; -.
DR   PDBsum; 5DXP; -.
DR   PDBsum; 5DXQ; -.
DR   PDBsum; 5DXR; -.
DR   PDBsum; 5DY8; -.
DR   PDBsum; 5DYB; -.
DR   PDBsum; 5DYD; -.
DR   PDBsum; 5DZ0; -.
DR   PDBsum; 5DZ1; -.
DR   PDBsum; 5DZ3; -.
DR   PDBsum; 5DZH; -.
DR   PDBsum; 5DZI; -.
DR   PDBsum; 5E0W; -.
DR   PDBsum; 5E0X; -.
DR   PDBsum; 5E14; -.
DR   PDBsum; 5E15; -.
DR   PDBsum; 5E19; -.
DR   PDBsum; 5E1C; -.
DR   PDBsum; 5EC9; -.
DR   PDBsum; 5EGV; -.
DR   PDBsum; 5EHJ; -.
DR   PDBsum; 5EI1; -.
DR   PDBsum; 5EIT; -.
DR   PDBsum; 5G3J; -.
DR   PDBsum; 5G42; -.
DR   PDBsum; 5G43; -.
DR   PDBsum; 5G44; -.
DR   PDBsum; 5G45; -.
DR   PDBsum; 5G46; -.
DR   PDBsum; 5G5W; -.
DR   PDBsum; 5H1E; -.
DR   PDBsum; 5HYR; -.
DR   PDBsum; 5I4V; -.
DR   PDBsum; 5IAW; -.
DR   PDBsum; 5ICK; -.
DR   PDBsum; 5KCC; -.
DR   PDBsum; 5KCD; -.
DR   PDBsum; 5KCE; -.
DR   PDBsum; 5KCF; -.
DR   PDBsum; 5KCT; -.
DR   PDBsum; 5KCU; -.
DR   PDBsum; 5KCW; -.
DR   PDBsum; 5KD9; -.
DR   PDBsum; 5KR9; -.
DR   PDBsum; 5KRA; -.
DR   PDBsum; 5KRC; -.
DR   PDBsum; 5KRF; -.
DR   PDBsum; 5KRH; -.
DR   PDBsum; 5KRI; -.
DR   PDBsum; 5KRJ; -.
DR   PDBsum; 5KRK; -.
DR   PDBsum; 5KRL; -.
DR   PDBsum; 5KRM; -.
DR   PDBsum; 5KRO; -.
DR   PDBsum; 5L11; -.
DR   PDBsum; 5LGA; -.
DR   PDBsum; 5SYZ; -.
DR   PDBsum; 5TLD; -.
DR   PDBsum; 5TLF; -.
DR   PDBsum; 5TLG; -.
DR   PDBsum; 5TLL; -.
DR   PDBsum; 5TLM; -.
DR   PDBsum; 5TLO; -.
DR   PDBsum; 5TLP; -.
DR   PDBsum; 5TLT; -.
DR   PDBsum; 5TLU; -.
DR   PDBsum; 5TLV; -.
DR   PDBsum; 5TLX; -.
DR   PDBsum; 5TLY; -.
DR   PDBsum; 5TM1; -.
DR   PDBsum; 5TM2; -.
DR   PDBsum; 5TM3; -.
DR   PDBsum; 5TM4; -.
DR   PDBsum; 5TM5; -.
DR   PDBsum; 5TM6; -.
DR   PDBsum; 5TM7; -.
DR   PDBsum; 5TM8; -.
DR   PDBsum; 5TM9; -.
DR   PDBsum; 5TML; -.
DR   PDBsum; 5TMM; -.
DR   PDBsum; 5TMO; -.
DR   PDBsum; 5TMQ; -.
DR   PDBsum; 5TMR; -.
DR   PDBsum; 5TMS; -.
DR   PDBsum; 5TMT; -.
DR   PDBsum; 5TMU; -.
DR   PDBsum; 5TMV; -.
DR   PDBsum; 5TMW; -.
DR   PDBsum; 5TMZ; -.
DR   PDBsum; 5TN1; -.
DR   PDBsum; 5TN3; -.
DR   PDBsum; 5TN4; -.
DR   PDBsum; 5TN5; -.
DR   PDBsum; 5TN6; -.
DR   PDBsum; 5TN7; -.
DR   PDBsum; 5TN8; -.
DR   ProteinModelPortal; Q15596; -.
DR   SMR; Q15596; -.
DR   BioGrid; 115761; 72.
DR   DIP; DIP-5997N; -.
DR   IntAct; Q15596; 21.
DR   MINT; MINT-122867; -.
DR   STRING; 9606.ENSP00000399968; -.
DR   BindingDB; Q15596; -.
DR   DrugBank; DB06871; 17-METHYL-17-ALPHA-DIHYDROEQUILENIN.
DR   DrugBank; DB07863; 2-chloro-5-nitro-N-phenylbenzamide.
DR   DrugBank; DB07708; 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL.
DR   DrugBank; DB07712; 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB02998; Methyltrienolone.
DR   DrugBank; DB08773; RALOXIFENE CORE.
DR   DrugBank; DB08601; tributylstannanyl.
DR   iPTMnet; Q15596; -.
DR   PhosphoSitePlus; Q15596; -.
DR   BioMuta; NCOA2; -.
DR   DMDM; 13626594; -.
DR   EPD; Q15596; -.
DR   MaxQB; Q15596; -.
DR   PaxDb; Q15596; -.
DR   PeptideAtlas; Q15596; -.
DR   PRIDE; Q15596; -.
DR   Ensembl; ENST00000452400; ENSP00000399968; ENSG00000140396.
DR   GeneID; 10499; -.
DR   KEGG; hsa:10499; -.
DR   UCSC; uc003xyn.2; human.
DR   CTD; 10499; -.
DR   DisGeNET; 10499; -.
DR   GeneCards; NCOA2; -.
DR   HGNC; HGNC:7669; NCOA2.
DR   HPA; HPA060243; -.
DR   MIM; 601993; gene.
DR   neXtProt; NX_Q15596; -.
DR   OpenTargets; ENSG00000140396; -.
DR   PharmGKB; PA31471; -.
DR   eggNOG; ENOG410IQ5S; Eukaryota.
DR   eggNOG; ENOG410XPF9; LUCA.
DR   GeneTree; ENSGT00530000063109; -.
DR   HOGENOM; HOG000230947; -.
DR   HOVERGEN; HBG052583; -.
DR   InParanoid; Q15596; -.
DR   KO; K11255; -.
DR   OMA; PSDMNGW; -.
DR   OrthoDB; EOG091G00US; -.
DR   PhylomeDB; Q15596; -.
DR   TreeFam; TF332652; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-192105; Synthesis of bile acids and bile salts.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   SignaLink; Q15596; -.
DR   SIGNOR; Q15596; -.
DR   ChiTaRS; NCOA2; human.
DR   EvolutionaryTrace; Q15596; -.
DR   GeneWiki; Nuclear_receptor_coactivator_2; -.
DR   GenomeRNAi; 10499; -.
DR   PRO; PR:Q15596; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000140396; -.
DR   CleanEx; HS_NCOA2; -.
DR   ExpressionAtlas; Q15596; baseline and differential.
DR   Genevisible; Q15596; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0017162; F:aryl hydrocarbon receptor binding; IPI:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:BHF-UCL.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001162; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0030375; F:thyroid hormone receptor coactivator activity; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:1904017; P:cellular response to Thyroglobulin triiodothyronine; IEA:Ensembl.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0030522; P:intracellular receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0045475; P:locomotor rhythm; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00083; HLH; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 1.10.287.1070; -; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR010011; DUF1518.
DR   InterPro; IPR032565; DUF4927.
DR   InterPro; IPR028822; NCOA2.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014920; Nuc_rcpt_coact_Ncoa-typ.
DR   InterPro; IPR017426; Nuclear_rcpt_coactivator.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR014935; SRC/p160_LXXLL.
DR   PANTHER; PTHR10684; PTHR10684; 1.
DR   PANTHER; PTHR10684:SF5; PTHR10684:SF5; 1.
DR   Pfam; PF07469; DUF1518; 1.
DR   Pfam; PF16279; DUF4927; 1.
DR   Pfam; PF08815; Nuc_rec_co-act; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08832; SRC-1; 1.
DR   PIRSF; PIRSF038181; Nuclear_receptor_coactivator; 1.
DR   SMART; SM01151; DUF1518; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   SUPFAM; SSF69125; SSF69125; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Biological rhythms;
KW   Complete proteome; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2   1464       Nuclear receptor coactivator 2.
FT                                /FTId=PRO_0000094402.
FT   DOMAIN       26     83       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   DOMAIN      119    183       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   REGION      691    743       CASP8AP2-binding. {ECO:0000250}.
FT   REGION      730   1121       Interaction with ARNTL.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOTIF       641    645       LXXLL motif 1.
FT   MOTIF       690    694       LXXLL motif 2.
FT   MOTIF       745    749       LXXLL motif 3.
FT   MOTIF       878    882       LXXLL motif 4.
FT   MOTIF      1079   1087       LLXXLXXXL motif.
FT   COMPBIAS   1254   1260       Poly-Gln.
FT   SITE        869    870       Breakpoint for translocation to form
FT                                KAT6A-NCOA2.
FT                                {ECO:0000269|PubMed:12676584,
FT                                ECO:0000269|PubMed:15657427,
FT                                ECO:0000269|PubMed:9558366}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     338    338       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOD_RES     487    487       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     493    493       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     554    554       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     565    565       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     636    636       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOD_RES     640    640       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     682    682       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     699    699       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     736    736       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     771    771       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     780    780       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     785    785       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     864    864       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOD_RES     874    874       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOD_RES    1173   1173       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1177   1177       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1190   1190       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1196   1196       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1203   1203       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1221   1221       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1240   1240       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q61026}.
FT   MOD_RES    1261   1261       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1266   1266       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    785    785       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447}.
FT   VARIANT    1282   1282       M -> I (in dbSNP:rs2228591).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024546.
FT   MUTAGEN     644    645       LL->AA: By itself, does not affect
FT                                nuclear receptor binding or
FT                                transcriptional coactivation. Abrogates
FT                                ligand-induced nuclear receptor binding
FT                                and transactivation; when associated with
FT                                693-A-A-694 and 748-A-A-749.
FT                                {ECO:0000269|PubMed:9430642}.
FT   MUTAGEN     693    694       LL->AA: By itself, does not affect
FT                                nuclear receptor binding or
FT                                transcriptional coactivation. Abrogates
FT                                ligand-induced nuclear receptor binding
FT                                and transactivation; when associated with
FT                                644-A-A-665 and 748-A-A-749.
FT                                {ECO:0000269|PubMed:9430642}.
FT   MUTAGEN     748    749       LL->AA: By itself, does not affect
FT                                nuclear receptor binding or
FT                                transcriptional coactivation. Abrogates
FT                                ligand-induced nuclear receptor binding
FT                                and transactivation; when associated with
FT                                644-A-A-665 and 693-A-A-694.
FT                                {ECO:0000269|PubMed:9430642}.
FT   MUTAGEN    1079   1083       LLDQL->AADQA: Reduces transcriptional
FT                                coactivation and disrupts interaction
FT                                with CREBBP/CBP.
FT                                {ECO:0000269|PubMed:9430642}.
FT   MUTAGEN    1081   1082       DQ->AA: Has little effect on
FT                                transcriptional coactivation.
FT                                {ECO:0000269|PubMed:9430642}.
FT   HELIX       689    693       {ECO:0000244|PDB:5DXE}.
FT   STRAND      739    741       {ECO:0000244|PDB:1M2Z}.
FT   HELIX       743    750       {ECO:0000244|PDB:3UP3}.
SQ   SEQUENCE   1464 AA;  159157 MW;  0A61AA5D1878304B CRC64;
     MSGMGENTSD PSRAETRKRK ECPDQLGPSP KRNTEKRNRE QENKYIEELA ELIFANFNDI
     DNFNFKPDKC AILKETVKQI RQIKEQEKAA AANIDEVQKS DVSSTGQGVI DKDALGPMML
     EALDGFFFVV NLEGNVVFVS ENVTQYLRYN QEELMNKSVY SILHVGDHTE FVKNLLPKSI
     VNGGSWSGEP PRRNSHTFNC RMLVKPLPDS EEEGHDNQEA HQKYETMQCF AVSQPKSIKE
     EGEDLQSCLI CVARRVPMKE RPVLPSSESF TTRQDLQGKI TSLDTSTMRA AMKPGWEDLV
     RRCIQKFHAQ HEGESVSYAK RHHHEVLRQG LAFSQIYRFS LSDGTLVAAQ TKSKLIRSQT
     TNEPQLVISL HMLHREQNVC VMNPDLTGQT MGKPLNPISS NSPAHQALCS GNPGQDMTLS
     SNINFPINGP KEQMGMPMGR FGGSGGMNHV SGMQATTPQG SNYALKMNSP SQSSPGMNPG
     QPTSMLSPRH RMSPGVAGSP RIPPSQFSPA GSLHSPVGVC SSTGNSHSYT NSSLNALQAL
     SEGHGVSLGS SLASPDLKMG NLQNSPVNMN PPPLSKMGSL DSKDCFGLYG EPSEGTTGQA
     ESSCHPGEQK ETNDPNLPPA VSSERADGQS RLHDSKGQTK LLQLLTTKSD QMEPSPLASS
     LSDTNKDSTG SLPGSGSTHG TSLKEKHKIL HRLLQDSSSP VDLAKLTAEA TGKDLSQESS
     STAPGSEVTI KQEPVSPKKK ENALLRYLLD KDDTKDIGLP EITPKLERLD SKTDPASNTK
     LIAMKTEKEE MSFEPGDQPG SELDNLEEIL DDLQNSQLPQ LFPDTRPGAP AGSVDKQAII
     NDLMQLTAEN SPVTPVGAQK TALRISQSTF NNPRPGQLGR LLPNQNLPLD ITLQSPTGAG
     PFPPIRNSSP YSVIPQPGMM GNQGMIGNQG NLGNSSTGMI GNSASRPTMP SGEWAPQSSA
     VRVTCAATTS AMNRPVQGGM IRNPAASIPM RPSSQPGQRQ TLQSQVMNIG PSELEMNMGG
     PQYSQQQAPP NQTAPWPESI LPIDQASFAS QNRQPFGSSP DDLLCPHPAA ESPSDEGALL
     DQLYLALRNF DGLEEIDRAL GIPELVSQSQ AVDPEQFSSQ DSNIMLEQKA PVFPQQYASQ
     AQMAQGSYSP MQDPNFHTMG QRPSYATLRM QPRPGLRPTG LVQNQPNQLR LQLQHRLQAQ
     QNRQPLMNQI SNVSNVNLTL RPGVPTQAPI NAQMLAQRQR EILNQHLRQR QMHQQQQVQQ
     RTLMMRGQGL NMTPSMVAPS GMPATMSNPR IPQANAQQFP FPPNYGISQQ PDPGFTGATT
     PQSPLMSPRM AHTQSPMMQQ SQANPAYQAP SDINGWAQGN MGGNSMFSQQ SPPHFGQQAN
     TSMYSNNMNI NVSMATNTGG MSSMNQMTGQ ISMTSVTSVP TSGLSSMGPE QVNDPALRGG
     NLFPNQLPGM DMIKQEGDTT RKYC
//
